CIS will begin to operate under Deloitteâs risk and financial advisory practice, Deloitte said Monday.
Owen Ryan, CEO of Deloitte Advisory, said the company intends for the CIS acquisition to help clients in the life sciences and healthcare industry address regulatory changes.
CIS will keep working to adapt business processes and controls to regulatory requirements in order to help life sciences clients manage risks, Deloitte says.